Komo Plant Based Foods Expands Distribution through Quality Foods Grocery Chain
Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved the fixed-dose combination of Opdualag (nivolumab and relatlimab) for the first-line...

